MEPERIDINE 43.57MG AS MEPERIDINE HYDROCHLORIDE
Disclaimer: These predictions are for research purposes only. They do not constitute medical advice and require clinical validation.
Overview
| Property | Value |
|---|---|
| Drug Name | MEPERIDINE 43.57MG AS MEPERIDINE HYDROCHLORIDE |
| DrugBank ID | DB00454 |
| HSA Status | Registered with Health Sciences Authority |
| KG Predictions | 18 |
| DL Predictions (≥0.7) | 50 |
Predicted Indications
The following indications are predicted based on TxGNN knowledge graph analysis:
| Indication | Source | Evidence |
|---|---|---|
| attention deficit-hyperactivity disorder | TxGNN Knowledge Graph | L5 |
| attention deficit hyperactivity disorder, inattentive type | TxGNN Knowledge Graph | L5 |
| osteoarthritis susceptibility | TxGNN Knowledge Graph | L5 |
| arthropathy | TxGNN Knowledge Graph | L5 |
| osteoarthritis | TxGNN Knowledge Graph | L5 |
| anxiety disorder | TxGNN Knowledge Graph | L5 |
| dysthymic disorder | TxGNN Knowledge Graph | L5 |
| neurotic disorder | TxGNN Knowledge Graph | L5 |
| lichen disease | TxGNN Knowledge Graph | L5 |
| anxiety | TxGNN Knowledge Graph | L5 |
Evidence Summary
External Resources
Generated by SgTxGNN on 2026-03-11